Virtu Financial LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$1.02 - $7.48 $11,561 - $84,785	11,335 New	11,335 $13,000
Q2 2022 Aug 09, 2022	SELL	$4.99 - $8.96 $271,920 - $488,257	-54,493 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$3.84 - $9.74 $121,858 - $309,089	31,734 Added 139.43%	54,493 $452,000
Q4 2021 Feb 17, 2022	BUY	$5.12 - $8.19 $116,526 - $186,396	22,759 New	22,759 $118,000
Q4 2020 Feb 24, 2021	SELL	$7.98 - $12.29 $97,052 - $149,470	-12,162 Closed	0 $0

Q3 2020 Dec 11, 2020	SELL	$7.96 - $12.42 $18,284 - $28,528	-2,297 Reduced 15.89%	12,162 $99,000
Q2 2020 Aug 07, 2020	BUY	$5.4 - $13.37 $78,078 - $193,316	14,459 New	14,459 $139,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $492M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.